22-Year-Old With Chronic Asthma Died After Inhaler Price Went From $66 to $539: Lawsuit
The parents of a 22-year-old Wisconsin man who died after an asthma attack have filed a lawsuit against Walgreens and ...
'Chose rent over his medicine': Parents of 22-year-old who died from asthma attack sue pharmacy over inhaler price jump
The parents of a young Wisconsin man have sued Walgreens and pharmacy benefit manager OptumRx over their son’s death from an ...
American Association of Individual Investors5h
Why Teva Pharmaceutical Industries Limited’s (TEVA) Stock Is Down 13.89%
Teva Pharmaceutical Industries Limited’s TEVA share price has dipped by 13.89%, which has investors questioning if this is ...
Le Lézard16h
SILENT SIGNALS: What Does Your Wordmark Whisper to Your Audience?
Every wordmark sends silent signals, subtle, often subconscious cues that influence how a brand is perceived. A new survey by LogoDek, reveals how font choice, font weight, letter spacing, color, ...
Teva's Growth Profile Looks Strong From Innovative Portfolio, Biosimilar Approvals and Deep Pipeline
We assign Teva a Morningstar Uncertainty Rating of High, which largely reflects our quantitative analysis of the firm, based on the return ranges used by our star rating system, as well as our ...
Le Lézard16h
Workday to Roll Out TechWolf's AI-Powered Skills Intelligence Across its Workforce, Making it Easier for Employees to Drive their Career Growth
Workday, Inc. , a leading provider of solutions to help organizations manage their people and money, and TechWolf today announced Workday will roll out TechWolf's AI-powered skills intelligence across ...
Healio18h
‘We applaud CMS’: Two more rheumatology drugs bound for Medicare price negotiation
The second round of Medicare Part D price negotiations will feature two drugs familiar to rheumatologists — Ofev and Otezla — ...